Risk, Results, and Costs: Optimizing Clinical Trial Efficiency through Prognostic Enrichment

Am J Respir Crit Care Med. 2021 Mar 15;203(6):671-672. doi: 10.1164/rccm.202009-3649ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Algorithms
  • Familial Primary Pulmonary Hypertension
  • Humans
  • Patient Selection
  • Prognosis
  • Pulmonary Arterial Hypertension*